Tali

What Tali does

Tali (Tali Digital Limited, formerly TALI Digital Limited, ASX-listed per company materials) is an Australian digital health medical device company headquartered in Melbourne. Founded in 2016, Tali develops clinically validated cognitive training and assessment software targeting attention difficulties in children aged 3-10. Its flagship product, ReadyAttentionGo, is a tablet-delivered, gamified digital therapeutic that uses neuroscientist-built algorithms to strengthen neural pathways responsible for selective, sustained, and executive attention, with reported benefits including improved attention and numeracy and reduced impulsive/hyperactive behavior. The companion product, TALi DETECT, was developed under the Australian Government's Cooperative Research Centres Program (CRC-P) and serves the assessment side of the workflow.

Tali monetizes via a subscription/recurring model in which the digital therapeutic is prescribed or recommended by healthcare providers, with progress reports generated throughout training and delivered back to the prescribing clinician. The go-to-market is enterprise field sales directed at healthcare providers and systems (pediatricians, allied health, clinical networks), rather than direct-to-consumer, and the medical device classification positions the product above general consumer wellness apps. The stated mission is to strengthen the attention of children globally, indicating intent to expand beyond the current Australian regional footprint.

The company operates with 11-50 employees, has raised at least $4.1M in disclosed funding (round dated 2022-12-23, investors undisclosed), and rebranded from TALI Digital Limited to Tali Digital Limited on 2023-10-04. No patents, named customers, or institutional investors are disclosed in the available source material, and revenue figures have not been published.

Name

Tali

Legal name

Tali Digital Limited

Website

https://talihealth.com

Company type

Public

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Tali is an Australian digital health medical device company (Tali Digital Limited) that builds clinically validated, tablet-based cognitive training and assessment software targeting children aged 3-10 with attention difficulties, sold to healthcare providers as a subscription digital therapeutic.

Ownership category

akta.pro rank

Product category

Pediatric Digital Therapeutics

NAICS

Educational Support Services (611710)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

AT for Reading, Writing & Learning (Literacy/Executive Function) Tools & Training (EDAKAIAC)

akta.pro secondary industries

Special Needs Skill-Building & Therapy Learning Apps (Autism, OT/PT, Life Skills) (EDAFAKAJ), Assessment & Screening Tools (Developmental, Readiness, Progress Monitoring) (EDACAJAC), Specialized Intervention & Skill-Building Programs (Speech/OT Support Materials, Social Skills) (EDACAJAJ)

Keywords

• Digital therapeutics
• Pediatric cognitive training
• Attention training software
• Medical device software
• Digital health platform

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Digital Therapeutic Program (ReadyAttentionGo): Subscription or per-use model for cognitive training program delivered via tablet, with ongoing reporting to healthcare providers. The medical device nature suggests recurring revenue through healthcare provider prescriptions or institutional purchases.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Tali develops and sells ReadyAttentionGo, an Australian-owned medical device and digital therapeutic that delivers a gamified, algorithm-driven cognitive training program on tablets for children aged 3-10. The scientifically validated program strengthens neural pathways responsible for selective, sustained, and executive attention, reduces impulsive and hyperactive behaviour, and improves numeracy skills, with progress reports generated and sent to the child's healthcare provider throughout the training.

Product overview

Tali is an Australian digital health medical device company offering a unified product portfolio centered on pediatric attention assessment and training. The core offering is ReadyAttentionGo, a medical device and digital therapeutic cognitive training program for children aged 3-10 years, paired with TALi DETECT (developed under the Australian Government's CRC-P program) for attention assessment. Both products leverage tablet-based gamified cognitive tasks and generate reports for healthcare providers.

Differentiator

Problem solved

Functional benefit

Brands

• ReadyAttentionGo: Australian owned medical device and digital therapeutic - a pioneering cognitive training program for 3-10 year olds that improves attention and numeracy skills and reduces impulsive and hyperactive behaviour

Products and services

• ReadyAttentionGo An Australian-owned medical device and digital therapeutic offering gamified, scientifically validated cognitive training for children aged 3-10 years. Delivered via tablet, it strengthens neural pathways responsible for selective, sustained, and executive attention, improves numeracy skills, and reduces impulsive and hyperactive behaviour. Reports are generated throughout training and sent to the child's healthcare provider.
• TALi DETECT An attention assessment tool developed under the Australian Government's Cooperative Research Centres Program (CRC-P), used in conjunction with the ReadyAttentionGo cognitive training program to identify attention needs in children.

Quantifiable outcome

• 95% of children maintained or improved attention skills

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• Akili Interactive: Developer of FDA-cleared EndeavorRx, a prescription pediatric digital therapeutic for attention — the closest direct competitor to TALi's ReadyAttentionGo, addressing overlapping ages (children with attention issues) via gamified cognitive training delivered through providers.
• Cogmed (Pearson Clinical): Working memory / attention training program marketed to clinicians, schools, and parents for children with attention difficulties — comparable distribution channel (provider-dispensed) and similar neurocognitive training approach to TALi.

Broad incumbents

• Posit Science (BrainHQ): Established cognitive training platform with clinically validated exercises targeting attention and executive function across age groups — comparable science-driven digital cognitive training methodology though broader (adult-skewing) than TALi's pediatric focus.
• Headspace Health: Digital mental health platform offering content and tools touching attention, focus, and child/family mental wellness — competes for parent and provider attention-training mindshare at a much larger scale.

Emerging players

• Big Health: Digital therapeutics company delivering evidence-based cognitive interventions (e.g., Sleepio) through healthcare providers — comparable prescription-mediated, evidence-validated digital therapeutic model targeting specific clinical indications.
• Limbic: AI-driven mental health digital therapeutic platform with provider integration — comparable clinical evidence–led, prescription-style digital therapeutic distribution in adjacent mental/neurodevelopmental health.
• MindMaze: Digital neuro-rehabilitation platform combining gamified cognitive tasks with clinical delivery for neurological conditions — overlaps TALi's gamified cognitive training for clinical indications and provider-led distribution.
• Woebot Health: Digital therapeutic for mental health using structured, clinically validated conversational/content programs — comparable digital therapeutic distribution to providers and self-pay families for pediatric mental health conditions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/TALIHealth
• Facebookfacebook.com/talihealth
• LinkedInlinkedin.com/company/talihealth

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tali